Prevalence of Autoimmune Disease Among Patients With Lung Cancer: Implications for Immunotherapy Treatment Options.
Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas2Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas.
Saad A
SA
Khan
Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas3Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas.
Sandi L
SL
Pruitt
Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas.
Lei
L
Xuan
Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas2Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas.
David E
DE
Gerber
D000368:Aged; D000369:Aged, 80 and over; D001327:Autoimmune Diseases / Q000453:epidemiology* / Q000209:etiology; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D008175:Lung Neoplasms / Q000276:immunology / Q000628:therapy*; D008297:Male; D015995:Prevalence